m+Medelevator.RU
← Поиск публикаций
Cureus · 2026

Mechanobiological Stimulation With Nanoencapsulated Recombinant Growth Factors Combined With Subcision for the Treatment of Complex Post-traumatic Atrophic Facial Scars: A Case Report.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Calfin Hector, Castro César, Riquelme Veronica

Аннотация

Post-traumatic atrophic scars represent a complex therapeutic challenge whose pathophysiology involves three concurrent structural deficits: reticular dermis degradation, formation of vertical fibrous tracts that anchor the skin to deep planes, and subcutaneous lipoatrophy. We present a three-session multimodal protocol at two-week intervals, applied to a 53-year-old female patient with atrophic scars of the right hemiface secondary to a motor vehicle accident, refractory to prior reconstructive surgery, autologous fat transfer, and 10 sessions of fractional CO₂ laser. The protocol integrated tumescent hydrodissection, subcision with a 22G blunt cannula, controlled adipose tunneling to activate the stromal vascular fraction (SVF) in situ, and immediate transepidermal and retrograde delivery of nanoencapsulated recombinant human growth factors (rh-GF). Objective assessment using the Vancouver Scar Scale (VSS) demonstrated a 50% reduction in total score (from 6 to 3 points out of 14), with the greatest gains in pliability (4 → 2) and height (1 → 0), maintained at six months of follow-up. The patient spontaneously reported reduced sensation of pressure and facial stiffness, as well as improvement in her self-esteem and perceived quality of life. This single-case report - with the limitations inherent to this study design - provides preliminary evidence that justifies the development of prospective controlled studies to evaluate the integration of mechanotransduction, adipose regeneration, and molecular signaling in complex scar defects.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты